Multicenter study of pegylated interferon α-2a monotherapy for hepatitis C virus-infected patients on hemodialysis: REACH study.
Kikuchi K, Akiba T, Nitta K, Masakane I, Ando R, Izumi N, Atsukawa M, Yamazaki C, Kato F, Hotta N, Tominaga Y, Orito E, Hora K, Nagasawa M, Kasahara H, Kawaguchi M, Kimura H, Ikebe N, Kawanishi H, Moriishi M, Shigemoto K, Harada T, Hirakata H, Watanabe H, Nosaki T, Tsubouchi H, Imawari M, Akizawa T.
Kikuchi K, et al. Among authors: ikebe n.
Ther Apher Dial. 2014 Dec;18(6):603-11. doi: 10.1111/1744-9987.12189. Epub 2014 Sep 4.
Ther Apher Dial. 2014.
PMID: 25196061
Clinical Trial.